Video Upload Options

References

1. Arefi M, García JL, Peñarrubia MJ, Queizán JA, Hermosín L, López-Corral L,Megido M, Giraldo P, de las Heras N, Vanegas RJ, Gutiérrez NC, Hernández-RivasJM. Incidence and clinical characteristics of myeloproliferative neoplasmsdisplaying a PDGFRB rearrangement. Eur J Haematol. 2012 Jul;89(1):37-41. doi:10.1111/j.1600-0609.2012.01799.x.
2. Cornish K, Bramble D. Cri du chat syndrome: genotype-phenotype correlationsand recommendations for clinical management. Dev Med Child Neurol. 2002Jul;44(7):494-7. Review.
3. Cross NC, Reiter A. Fibroblast growth factor receptor and platelet-derivedgrowth factor receptor abnormalities in eosinophilic myeloproliferativedisorders. Acta Haematol. 2008;119(4):199-206. doi: 10.1159/000140631.
4. Eisenmann KM, Dykema KJ, Matheson SF, Kent NF, DeWard AD, West RA, Tibes R,Furge KA, Alberts AS. 5q- myelodysplastic syndromes: chromosome 5q genes direct atumor-suppression network sensing actin dynamics. Oncogene. 2009 Oct1;28(39):3429-41. doi: 10.1038/onc.2009.207.
5. Giagounidis A, Mufti GJ, Fenaux P, Germing U, List A, MacBeth KJ. Lenalidomideas a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Ann Hematol. 2014Jan;93(1):1-11. doi: 10.1007/s00277-013-1863-5.
6. Hunt D, Leventer RJ, Simons C, Taft R, Swoboda KJ, Gawne-Cain M; DDD study,Magee AC, Turnpenny PD, Baralle D. Whole exome sequencing in family trios revealsde novo mutations in PURA as a cause of severe neurodevelopmental delay andlearning disability. J Med Genet. 2014 Dec;51(12):806-13. doi:10.1136/jmedgenet-2014-102798.
7. Kumar MS, Narla A, Nonami A, Mullally A, Dimitrova N, Ball B, McAuley JR,Poveromo L, Kutok JL, Galili N, Raza A, Attar E, Gilliland DG, Jacks T, Ebert BL.Coordinate loss of a microRNA and protein-coding gene cooperate in thepathogenesis of 5q- syndrome. Blood. 2011 Oct 27;118(17):4666-73. doi:10.1182/blood-2010-12-324715.
8. Lalani SR, Zhang J, Schaaf CP, Brown CW, Magoulas P, Tsai AC, El-Gharbawy A,Wierenga KJ, Bartholomew D, Fong CT, Barbaro-Dieber T, Kukolich MK, Burrage LC,Austin E, Keller K, Pastore M, Fernandez F, Lotze T, Wilfong A, Purcarin G, ZhuW, Craigen WJ, McGuire M, Jain M, Cooney E, Azamian M, Bainbridge MN, Muzny DM,Boerwinkle E, Person RE, Niu Z, Eng CM, Lupski JR, Gibbs RA, Beaudet AL, Yang Y, Wang MC, Xia F. Mutations in PURA cause profound neonatal hypotonia, seizures,and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet. 2014 Nov6;95(5):579-83. doi: 10.1016/j.ajhg.2014.09.014.
9. Mainardi PC, Perfumo C, Calì A, Coucourde G, Pastore G, Cavani S, Zara F,Overhauser J, Pierluigi M, Bricarelli FD. Clinical and molecular characterisationof 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet.2001 Mar;38(3):151-8.
10. Schafer IA, Robin NH, Posch JJ, Clark BA, Izumo S, Schwartz S. Distal 5qdeletion syndrome: phenotypic correlations. Am J Med Genet. 2001 Sep15;103(1):63-8. Review.
11. Schmutz J, Martin J, Terry A, Couronne O, Grimwood J, Lowry S, Gordon LA,Scott D, Xie G, Huang W, Hellsten U, Tran-Gyamfi M, She X, Prabhakar S, Aerts A, Altherr M, Bajorek E, Black S, Branscomb E, Caoile C, Challacombe JF, Chan YM,Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Glavina T, Gomez M,Gonzales E, Goodstein D, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L,Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Lopez F, Lou Y, Martinez D,Medina C, Morgan J, Nandkeshwar R, Noonan JP, Pitluck S, Pollard M, Predki P,Priest J, Ramirez L, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A,Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wheeler J, Wu K, Yang J, DicksonM, Cheng JF, Eichler EE, Olsen A, Pennacchio LA, Rokhsar DS, Richardson P, Lucas SM, Myers RM, Rubin EM. The DNA sequence and comparative analysis of humanchromosome 5. Nature. 2004 Sep 16;431(7006):268-74.
12. Shimojima K, Isidor B, Le Caignec C, Kondo A, Sakata S, Ohno K, Yamamoto T. A new microdeletion syndrome of 5q31.3 characterized by severe developmentaldelays, distinctive facial features, and delayed myelination. Am J Med Genet A.2011 Apr;155A(4):732-6. doi: 10.1002/ajmg.a.33891.Am J Med Genet A. 2011 Nov;155A(11):2903.
13. Siddiqi R, Gilbert F. Chromosome 5. Genet Test. 2003 Summer;7(2):169-87.
14. Wu Q, Niebuhr E, Yang H, Hansen L. Determination of the 'critical region' for cat-like cry of Cri-du-chat syndrome and analysis of candidate genes byquantitative PCR. Eur J Hum Genet. 2005 Apr;13(4):475-85.
15. Zhang X, Snijders A, Segraves R, Zhang X, Niebuhr A, Albertson D, Yang H, GrayJ, Niebuhr E, Bolund L, Pinkel D. High-resolution mapping of genotype-phenotyperelationships in cri du chat syndrome using array comparative genomichybridization. Am J Hum Genet. 2005 Feb;76(2):312-26.